210 related articles for article (PubMed ID: 33353827)
21. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
22. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
Keck KJ; Maxwell JE; Menda Y; Bellizzi A; Dillon J; O'Dorisio TM; Howe JR
Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial.
De Nardi P; Elmore U; Maggi G; Maggiore R; Boni L; Cassinotti E; Fumagalli U; Gardani M; De Pascale S; Parise P; Vignali A; Rosati R
Surg Endosc; 2020 Jan; 34(1):53-60. PubMed ID: 30903276
[TBL] [Abstract][Full Text] [Related]
24. Indocyanine green fluorescence angiography in pediatric intestinal resections: A first prospective mixed methods clinical trial.
Le-Nguyen A; Bourque CJ; Trudeau MO; Ducruet T; Faure C; Piché N
J Pediatr Surg; 2023 Jan; 58(1):82-88. PubMed ID: 36357227
[TBL] [Abstract][Full Text] [Related]
25. Role of Primary Tumor Resection for Metastatic Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):213-218. PubMed ID: 32797281
[TBL] [Abstract][Full Text] [Related]
26. Transanal total mesorectal excision for rectal cancer with indocyanine green fluorescence angiography.
Mizrahi I; de Lacy FB; Abu-Gazala M; Fernandez LM; Otero A; Sands DR; Lacy AM; Wexner SD
Tech Coloproctol; 2018 Oct; 22(10):785-791. PubMed ID: 30430309
[TBL] [Abstract][Full Text] [Related]
27. Lymphadenectomy during Small Bowel Neuroendocrine Tumor Surgery: The Concept of Skip Metastases.
Pasquer A; Walter T; Rousset P; Hervieu V; Forestier J; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):804-808. PubMed ID: 27613554
[TBL] [Abstract][Full Text] [Related]
28. Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs.
Cuccurullo V; Di Stasio GD; Mansi L
Nucl Med Rev Cent East Eur; 2017; 20(1):49-56. PubMed ID: 28218348
[TBL] [Abstract][Full Text] [Related]
29. Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
Sauvanet A
Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831
[TBL] [Abstract][Full Text] [Related]
30. Indocyanine green fluorescence angiography: a new ERAS item.
Brescia A; Pezzatini M; Romeo G; Cinquepalmi M; Pindozzi F; Dall'Oglio A; Gasparrini M; Lazar F
Updates Surg; 2018 Dec; 70(4):427-432. PubMed ID: 30173365
[TBL] [Abstract][Full Text] [Related]
31. The Distal Predilection of Small Bowel Neuroendocrine Tumors.
Keck KJ; Maxwell JE; Utria AF; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2018 Oct; 25(11):3207-3213. PubMed ID: 30054825
[TBL] [Abstract][Full Text] [Related]
32. Indocyanine green-enhanced fluorescence to assess bowel perfusion during laparoscopic colorectal resection.
Boni L; David G; Dionigi G; Rausei S; Cassinotti E; Fingerhut A
Surg Endosc; 2016 Jul; 30(7):2736-42. PubMed ID: 26487209
[TBL] [Abstract][Full Text] [Related]
33. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
34. [Intraoperative fluorescence angiography in colorectal surgery].
Carus T; Pick P
Chirurg; 2019 Nov; 90(11):887-890. PubMed ID: 31620821
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence angiography with indocyanine green (ICG) to evaluate anastomosis in colorectal surgery: where does it have more value?
Morales-Conde S; Alarcón I; Yang T; Licardie E; Camacho V; Aguilar Del Castillo F; Balla A
Surg Endosc; 2020 Sep; 34(9):3897-3907. PubMed ID: 31586247
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
37. Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study.
Carlsen EA; Fazio N; Granberg D; Grozinsky-Glasberg S; Ahmadzadehfar H; Grana CM; Zandee WT; Cwikla J; Walter MA; Oturai PS; Rinke A; Weaver A; Frilling A; Gritti S; Arveschoug AK; Meirovitz A; Knigge U; Sorbye H
Endocr Relat Cancer; 2019 Feb; 26(2):227-239. PubMed ID: 30540557
[TBL] [Abstract][Full Text] [Related]
38. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms.
Iabichino G; Di Leo M; Arena M; Rubis Passoni GG; Morandi E; Turpini F; Viaggi P; Luigiano C; De Luca L
World J Gastroenterol; 2022 Sep; 28(34):4943-4958. PubMed ID: 36160644
[TBL] [Abstract][Full Text] [Related]
40. Surgical Management of Primary Small Bowel NET Presenting Acutely with Obstruction or Perforation.
Rajaretnam NS; Meyer-Rochow GY;
World J Surg; 2021 Jan; 45(1):203-207. PubMed ID: 32696097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
